SPHK2 and neoplasm: The two isoforms of SphK, SphK1, and SphK2, catalyse the conversion of the membrane phospholipid sphingosine to the bioactive lipid S1P, an oncogenic mediator which drives a number of vital processes in tumor cells, including cell growth, survival, migration, invasion, and angiogenesis [38].